Notizia

Posted on


 

For Inflectra launch, Pfizer uses ‘hybrid model’ to home in on HCPs

US FDA approves Rubraca to treat advanced ovarian cancer

EMA approves MSD’s PD-1 therapy Keytruda to treat patients with NSCLC

Mylan launches authorized generic version of EpiPen

Source: Notizia

Advertisements